Somerset Indus Capital Partners, a healthcare-focused private equity firm, has closed its fifth investment from its second fund with a minority stake in a pharma ..
India s Glenmark Pharmaceuticals Ltd is considering selling a majority of the 82% stake it holds in Glenmark Life Sciences Ltd as it looks to lower its debt load, the Mint business daily reported. | April 11, 2023
The company had explored a stake sale in its active pharmaceutical ingredient (API) business in 2019 but then opted for a listing in 2021 after spinning off the entity as Glenmark Life Sciences